pharmacogenomics

October 23, 2018

Mayo Clinic research combines genetics and psychiatry to seek biomarkers for precise alcohol abuse therapies

By Susan Buckles Susan Buckles (@susanbuckles)

Mayo Clinic research is bringing together knowledge of psychiatry, genetics, metabolomics, pharmacogenomics and artificial intelligence to seek biological markers associated with alcohol use disorder and treatment response. Finding the molecular drivers of alcohol use disorder commonly known as alcoholism, could help predict who is most likely to develop this disorder and who might respond to […]

View full entry

Tags: Alcohol use disorder, Alcoholism, Alcoholism Recovery, Dr. Richard Weinshilboum, Dr. Victor Karpyak, Hazelden Betty Ford Foundation, Mayo Clinic Center for Individualized Medicine


September 17, 2018

CIMCON18 — how genomics discovery is transforming individualized care and the path forward

By Sharon Rosen Sharon Rosen (@sharonhrosen)

Mining information deeper than genomics, understanding factors linked to disease, analyzing big data, and addressing the challenges of bringing all this information together to advance patient care – these were some of the themes featured at the Individualizing Medicine Conference: Advancing Care through Genomics held in Rochester, Minnesota, Sept. 12-13, and sponsored by the Mayo […]

View full entry

Tags: #All of Us Research Program biobank, #CAR T-cell therapy, #CIMCon18, #Dr. Eric Green, #Dr. Gabriel Krestin, #Dr. Manolis Kellis, #Dr. Michael Berger, #Dr. Nancy Cox, #Dr. Yi Lin, #Genomic data, All of Us Research Program, center for individualized medicine


March 20, 2018

Mayo’s RIGHT 10K – moving pharmacogenomics into everyday clinical practice

By Sharon Rosen Sharon Rosen (@sharonhrosen)

After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results for 10,000 Mayo Clinic patients, all participants in the RIGHT 10K study, are being added to the electronic health record. “I’ve spent my career exploring pharmacogenomics – how a person’s genetics affect […]

View full entry

Tags: #CIMCon18, #DNA sequencing tests, #Dr. Paul Takahashi, #drug-gene interactions, #pharmacogenomic testing, #RIGHT 10K, center for individualized medicine, DNA, Dr. Richard Weinshilboum, genomics, mayo clinic, medical research


Contact Us · Privacy Policy